Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme - Related Studies

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

This study has been completed.

Study NCT00028678. Last updated on August 6, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Glioblastoma
		Nervous System Neoplasms

2	More general conditions related to this trial
		Astrocytoma
		Glioma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases
		Neuroectodermal Tumors

3	Interventions listed in this trial
		dalteparin
		radiation therapy

4	More general drug interventions related to this trial
		Anticoagulants
		Cardiovascular Agents
		Fibrin Modulating Agents
		Fibrinolytic Agents
		Hematologic Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		Eastern Cooperative Oncology Group
		National Cancer Institute (NCI)